Stay updated with breaking news from Assertio Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging...
/PRNewswire/ -- As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging...
Future Market Insights' (FMI's) latest survey provides an unbiased analysis of the opioid analgesics market, presenting historical demand data (2016-2020) and forecast statistics for the period
NEW YORK and BASEL, Switzerland, June 28, 2021 /PRNewswire/ -- Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced the appointment of Stanley J. Musial as chief financial officer (CFO) effective immediately. Mr. Musial brings over twenty-five years of experience building corporate value through operational execution, financial strategy and capital fundraising. "Stan's expertise in managing financials and raising capital at both private and public biotechnology companies comes at an important time as Aruvant goes through substantial g...
Pharmaceutical firms may have engaged in “bad faith” by failing to inform a judge overseeing a patent settlement in 2012 about an allegedly anticompetitive side deal, a federal judge said Thursday. SAN FRANCISCO (CN) — In a class action seeking billions of dollars from pharmaceutical firms accused of plotting to jack up the price of an essential diabetes drug, a federal judge said Thursday drug companies may have a hard time justifying the price increase to a jury. “I don’t think you’ll ever be able to explain to a jury $51 a pill when it was $5 before,” U.S. District Judge Will...